Consistent with increased mtDNA content, the PGC-1α, TFAM, and NRF1 expression levels were greater in PCOS patient-derived iPSCs compared with non-PCOS patient-derived iPSCs (Fig. 5f, g). This evidence concerns the gene PPARGC1A and polycystic ovary syndrome.